𝔖 Bobbio Scriptorium

✦ LIBER ✦

MP-11.03: Midodrine for the Treatment of Organic Anejaculation but Not Spinal Cord Injury: A Prospective Randomized Placebo-Controlled Double-Blind Clinical Study

✍ Scribed by M. Safarinejad

Book ID: 116951851
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 126 KB
Volume: 74
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2009.07.908

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liposomal Recombinant Human Superoxide D

Liposomal Recombinant Human Superoxide Dismutase for the Treatment of Peyronie's Disease: A Randomized Placebo-Controlled Double-Blind Prospective Clinical Study

✍ Claus R. Riedl; Peter Sternig; Günter Gallé; Florian Langmann; Brigitta Vcelar; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 226 KB

A 17-week, randomized, double-blind, pla

A 17-week, randomized, double-blind, placebo-controlled, parallel-group, multi-center trial of pregabalin for the treatment of chronic central neuropathic pain after spinal cord injury

✍ D. Cardenas; E. Nieshoff; K. Suda; S. Goto; T. Kaneko; B. Parsons; L. Sanin; M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB